Back to Journals » Drug Design, Development and Therapy » Volume 11

Baracle® vs Baraclude® for 48 weeks in patients with treatment-naïve chronic hepatitis B: a comparison of efficacy and safety

Total article views   HTML views PDF downloads Totals
10,236 Dovepress* 8,738+ 809 9,547
PubMed Central* 1,498 208 1,706
Totals 10,236 1,017 11,253
*Since 31 October 2017

View citations on PubMed Central and Google Scholar